---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-007782"
form_type: "8-K"
ticker: null
cik: "0001736865"
company_name: "Golden Developing Solutions, Inc."
filed_at: "2022-11-15T23:59:59+00:00"
generated_at: "2026-06-21T18:39:21.518446+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Golden Developing Solutions closes two pharmacy asset acquisitions for $5.3M total

## Summary
- Acquired Sai Siva Healthcare assets (Miami pharmacy) for $3,050,000; includes $650K inventory and $2.39M RX data.
- Acquired Bushnell Pharmacy assets (Southlake, TX) for $2,250,000; includes $550K inventory and $1.69M RX data.
- Both closings occurred on November 9, 2022; acquisitions had no due diligence condition.
- Financial statements for acquired entities to be filed by amendment within 71 days.

## SEC filing metadata
- accession: 0001683168-22-007782
- form_type: 8-K
- cik: 0001736865
- company_name: Golden Developing Solutions, Inc.
- filed_at: 2022-11-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1736865/000168316822007782/0001683168-22-007782-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1736865/000168316822007782/golden_8k-102022.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-007782
- JSON: https://secwatch.observer/filing/0001683168-22-007782.json
- Plain text: https://secwatch.observer/filing/0001683168-22-007782.txt

## Key facts
- M&A Transactions
  Golden Developing Solutions, Inc. completed an acquisition involving Bushnell Pharmacy LLC for $2,250,000, which included inventory of $550,000, RX Data of $1,690,000 and member's non-compete contribution of $10,000 (closed 2022-11-09).
  - Action: acquisition
  - Counterparty: Bushnell Pharmacy LLC
  - Consideration: $2,250,000, which included inventory of $550,000, RX Data of $1,690,000 and member's non-compete contribution of $10,000
  - Closing: 2022-11-09
  source text: As previously announced, on October 4, 2022, the Company entered into a second Asset Purchase and Sale Agreement (the “APA Two”) with Bushnell Pharmacy LLC, a Florida limited liability company (“Seller Two”), pursuant to which the Company was to purchase certain assets currently utilized in the operation of Seller Two’s pharmacy located at 1304 Golden Gate Drive, Southlake, TX 76092. The purchase price under the APA Two was $2,250,000, which included inventory of $550,000, RX Data of $1,690,000 and member’s non-compete contribution of $10,000. Closing was not conditioned on the completion of the any due diligence. On November 9, 2022, the Company completed the acquisition of the assets from Seller Two pursuant to the terms of APA Two.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1736865/000168316822007782/0001683168-22-007782-index.htm
- M&A Transactions
  Golden Developing Solutions, Inc. completed an acquisition involving Sai Siva Healthcare, LLC for $3,050,000, which included inventory of $650,000, RX Data of $2,390,000 and member's non-compete contribution of $10,000 (closed 2022-11-09).
  - Action: acquisition
  - Counterparty: Sai Siva Healthcare, LLC
  - Consideration: $3,050,000, which included inventory of $650,000, RX Data of $2,390,000 and member's non-compete contribution of $10,000
  - Closing: 2022-11-09
  source text: As previously announced, on October 4, 2022, Golden Developing Solutions, Inc., a Nevada corporation (“we”, “us” or the “Company”) entered into an Asset Purchase and Sale Agreement (the “APA One”) with Sai Siva Healthcare, LLC, a Florida limited liability company (“Seller”), pursuant to which the Company was to purchase certain assets currently utilized in the operation of Seller’s pharmacy located at 12753 S.W. 42 nd St., Miami, FL 33175. The purchase price under the APA One was $3,050,000, which included inventory of $650,000, RX Data of $2,390,000 and member’s non-compete contribution of $10,000. Closing was not conditioned on the completion of the any due diligence. On November 9, 2022, the Company completed the acquisition of the assets from Seller pursuant to the terms of APA One.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1736865/000168316822007782/0001683168-22-007782-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.